TY - JOUR T1 - Real-Time Microfluidic Blood-Counting System for PET and SPECT Preclinical Pharmacokinetic Studies JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1460 LP - 1466 DO - 10.2967/jnumed.115.162768 VL - 57 IS - 9 AU - Laurence Convert AU - Réjean Lebel AU - Suzanne Gascon AU - Réjean Fontaine AU - Jean-François Pratte AU - Paul Charette AU - Vincent Aimez AU - Roger Lecomte Y1 - 2016/09/01 UR - http://jnm.snmjournals.org/content/57/9/1460.abstract N2 - Small-animal nuclear imaging modalities have become essential tools in the development process of new drugs, diagnostic procedures, and therapies. Quantification of metabolic or physiologic parameters is based on pharmacokinetic modeling of radiotracer biodistribution, which requires the blood input function in addition to tissue images. Such measurements are challenging in small animals because of their small blood volume. In this work, we propose a microfluidic counting system to monitor rodent blood radioactivity in real time, with high efficiency and small detection volume (∼1 μL). Methods: A microfluidic channel is built directly above unpackaged p-i-n photodiodes to detect β-particles with maximum efficiency. The device is embedded in a compact system comprising dedicated electronics, shielding, and pumping unit controlled by custom firmware to enable measurements next to small-animal scanners. Data corrections required to use the input function in pharmacokinetic models were established using calibrated solutions of the most common PET and SPECT radiotracers. Sensitivity, dead time, propagation delay, dispersion, background sensitivity, and the effect of sample temperature were characterized. The system was tested for pharmacokinetic studies in mice by quantifying myocardial perfusion and oxygen consumption with 11C-acetate (PET) and by measuring the arterial input function using 99mTcO4− (SPECT). Results: Sensitivity for PET isotopes reached 20%–47%, a 2- to 10-fold improvement relative to conventional catheter-based geometries. Furthermore, the system detected 99mTc-based SPECT tracers with an efficiency of 4%, an outcome not possible through a catheter. Correction for dead time was found to be unnecessary for small-animal experiments, whereas propagation delay and dispersion within the microfluidic channel were accurately corrected. Background activity and sample temperature were shown to have no influence on measurements. Finally, the system was successfully used in animal studies. Conclusion: A fully operational microfluidic blood-counting system for preclinical pharmacokinetic studies was developed. Microfluidics enabled reliable and high-efficiency measurement of the blood concentration of most common PET and SPECT radiotracers with high temporal resolution in small blood volume. ER -